The global Abdominal Aortic Aneurysm (AAA) Treatment Market is expected to witness steady growth as healthcare providers increasingly adopt advanced surgical and minimally invasive endovascular procedures to treat abdominal aortic aneurysms. According to Future Market Insights (FMI), the market is projected to expand from USD 2.4 billion in 2026 to USD 4.1 billion by 2036, registering a CAGR of 5.3% during the forecast period. Rising aneurysm diagnosis through screening programs, increasing adoption of endovascular aneurysm repair (EVAR), expanding hospital infrastructure, and technological advancements in stent graft systems are expected to support market expansion.

👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-1359

The market is anticipated to generate significant growth opportunities between 2026 and 2036, supported by increasing investments in vascular surgery technologies, growing awareness of aneurysm screening, expanding access to minimally invasive procedures, and continuous innovation in endovascular devices.

Key Abdominal Aortic Aneurysm Treatment Market Highlights

· Market Size (2026): USD 2.4 Billion

· Forecast Market Size (2036): USD 4.1 Billion

· Forecast Period: 2026–2036

· CAGR (2026–2036): 5.3%

· Key Segments Covered: Treatment, End User Type, Diagnosis Type, Region

· Regions Covered: North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa

· Countries Covered: United States, China, India, European Union, South Korea, Japan, United Kingdom, and other major markets

Analyst Viewpoint

Anurag Sharma, Principal Consultant at Future Market Insights, stated:

"The increasing shift toward minimally invasive endovascular aneurysm repair is transforming abdominal aortic aneurysm treatment worldwide. Manufacturers that deliver durable stent graft technologies, reliable deployment systems, and strong clinical outcomes will be well-positioned to benefit from rising aneurysm diagnosis and expanding vascular surgery programs over the coming decade."

Why Is the Abdominal Aortic Aneurysm Treatment Market Growing?

The abdominal aortic aneurysm treatment market continues to expand as healthcare systems strengthen screening programs for high-risk populations and improve access to advanced vascular surgery. Early diagnosis through ultrasound imaging enables timely intervention, reducing the risk of aneurysm rupture and improving patient outcomes.

Growing adoption of endovascular aneurysm repair (EVAR), increasing prevalence of age-related vascular disorders, rising demand for minimally invasive procedures, and continuous innovation in stent graft technology are supporting market growth. Hospitals remain the primary treatment centers due to the complexity of aneurysm repair procedures and the need for specialized surgical expertise.

Key Growth Drivers

· Rising incidence of abdominal aortic aneurysms among elderly populations

· Increasing adoption of minimally invasive endovascular aneurysm repair

· Growing awareness and implementation of ultrasound screening programs

· Advancements in stent graft technologies

· Expansion of hospital vascular surgery capabilities

· Increasing healthcare investments in cardiovascular care

· Growing demand for improved procedural outcomes

· Rising availability of advanced diagnostic imaging technologies

👉 Explore the Latest Healthcare Industry Analysis Now:
https://www.futuremarketinsights.com/industry-analysis/healthcare-services

Key Segment Insights

Which Treatment Segment Leads the Abdominal Aortic Aneurysm Treatment Market?

Surgery remains the leading treatment segment, accounting for 62.0% of the market in 2026 owing to the widespread use of both open surgical repair and endovascular aneurysm repair for managing abdominal aortic aneurysms.

Treatment Highlights

· Surgery leads with 62.0% market share

· Includes open surgical repair and EVAR procedures

· Strong adoption across vascular surgery centers

· Improved clinical outcomes through advanced surgical techniques

Which End User Holds the Largest Market Share?

Hospitals dominate the end-user segment with 68.0% market share due to their advanced surgical infrastructure, specialized vascular care teams, and access to sophisticated imaging technologies.

End User Highlights

· Hospitals account for 68.0% market share

· Primary centers for aneurysm diagnosis and treatment

· Equipped with advanced vascular surgery facilities

· Growing adoption of minimally invasive procedures

Which Patient Group Represents the Largest Share?

Elderly Patients account for 46.0% of the market, reflecting the higher prevalence of abdominal aortic aneurysms among aging populations and the increasing demand for specialized vascular care.

Market Dynamics

Market Drivers

Increasing aneurysm diagnosis through screening programs, rising adoption of endovascular repair, expanding hospital infrastructure, technological advancements in stent graft systems, growing elderly populations, and improved vascular surgery techniques continue driving market growth.

Market Restraints

High procedural costs, limited access to specialized vascular surgery centers, stringent regulatory requirements, risks associated with complex surgical procedures, post-operative complications, and reimbursement challenges continue to restrain broader market expansion.

👉 Access the Complete Report in PDF Format: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1359

Market Trends

Innovation continues reshaping the Abdominal Aortic Aneurysm Treatment Market.

Major trends include:

· Increasing adoption of endovascular aneurysm repair (EVAR)

· Development of next-generation stent graft technologies

· Expansion of ultrasound-based screening programs

· Rising demand for minimally invasive vascular procedures

· Integration of advanced imaging technologies into surgical planning

· Growing investment in vascular surgery infrastructure

· Increasing focus on improving long-term procedural outcomes

Regional Outlook

North America continues to account for a significant market share owing to advanced healthcare infrastructure, high adoption of endovascular procedures, strong vascular surgery programs, and increasing awareness of aneurysm screening.

Europe maintains steady growth supported by expanding screening initiatives, favorable reimbursement policies, and widespread availability of specialized vascular treatment centers.

Asia Pacific is expected to witness the fastest growth during the forecast period due to expanding healthcare infrastructure, increasing diagnosis rates, rising investments in cardiovascular care, and growing adoption of minimally invasive procedures across China, India, Japan, and South Korea.

Meanwhile, Latin America and the Middle East & Africa are expected to create emerging opportunities as healthcare access improves and investments in vascular disease management continue to increase.

Competitive Landscape

Competition continues intensifying as leading manufacturers invest in advanced stent graft technologies, product innovation, clinical research, strategic partnerships, manufacturing expansion, and global commercialization to strengthen their market position.

Major Abdominal Aortic Aneurysm Treatment Market Global Key Companies

· Medtronic

· Johnson & Johnson

· Cook Medical

· Endologix

· Boston Scientific

· Terumo

· Abbott Laboratories

· Bard Peripheral Vascular

👉 Custom Research Available | Exclusive Discounts on Full Report: https://www.futuremarketinsights.com/reports/abdominal-aortic-aneurysm-treatment-market

Frequently Asked Questions

1. What is the projected size of the Abdominal Aortic Aneurysm Treatment Market by 2036?

The global Abdominal Aortic Aneurysm Treatment Market is projected to reach USD 4.1 billion by 2036, growing from USD 2.4 billion in 2026.

2. What is the expected CAGR of the Abdominal Aortic Aneurysm Treatment Market?

The market is expected to expand at a CAGR of 5.3% between 2026 and 2036.

3. What is driving market growth?

Rising aneurysm diagnosis through ultrasound screening, increasing adoption of endovascular aneurysm repair, growing elderly populations, advancements in stent graft technology, and expanding hospital vascular surgery programs are the primary market growth drivers.

4. Which treatment segment dominates the market?

Surgery currently leads the market with a 62.0% share, supported by the widespread adoption of open surgical repair and minimally invasive EVAR procedures.

5. Which end-user segment holds the largest share?

Hospitals lead the market with a 68.0% share due to their specialized vascular surgery capabilities and advanced diagnostic infrastructure.

Related Reports

· https://www.openpr.com/news/4589246/regenerative-medicine-market-size-anticipated-to-reach-usd-23-8

· https://www.openpr.com/news/4589251/what-is-driving-the-rapid-expansion-of-the-anti-infective

· https://www.openpr.com/news/4589255/why-is-the-usa-emerging-as-a-key-growth-hub-for-the-bone-marrow

· https://www.openpr.com/news/4589260/abdominal-aortic-aneurysm-treatment-market-size-anticipated

· https://www.openpr.com/news/4589261/chemotherapy-induced-myelosuppression-treatment-market-size



About Future Market Insights (FMI)

Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries. The firm delivers detailed forecasts, technology analysis, and data-driven recommendations that support informed decision-making for manufacturers, investors, distributors, and policymakers worldwide.

For Press & Corporate Inquiries

Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075

For Sales – [email protected]
For Media – [email protected]
For Web – https://www.futuremarketinsights.com